GSA Capital Partners’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $320K | Buy |
+2,493
| New | +$292K | 0.02% | 1264 |
|
|
2025
Q4 | – | Sell |
-24,809
| Closed | -$2.08M | – | 1944 |
|
|
2025
Q3 | $2.08M | Buy |
24,809
+12,871
| +108% | +$1.06M | 0.17% | 76 |
|
|
2025
Q2 | $945K | Sell |
11,938
-15,143
| -56% | -$1.2M | 0.07% | 495 |
|
|
2025
Q1 | $2.43M | Buy |
27,081
+8,401
| +45% | +$784K | 0.22% | 33 |
|
|
2024
Q4 | $1.86M | Buy |
18,680
+5,971
| +47% | +$616K | 0.14% | 103 |
|
|
2024
Q3 | $1.44M | Buy |
+12,709
| New | +$1.51M | 0.11% | 245 |
|
|
2024
Q2 | – | Sell |
-2,173
| Closed | -$287K | – | 1893 |
|
|
2024
Q1 | $287K | Buy |
+2,173
| New | +$268K | 0.02% | 1243 |
|
|
2022
Q3 | – | Sell |
-6,945
| Closed | -$633K | – | 1753 |
|
|
2022
Q2 | $633K | Sell |
6,945
-4,780
| -41% | -$424K | 0.1% | 362 |
|
|
2022
Q1 | $962K | Buy |
+11,725
| New | +$924K | 0.13% | 194 |
|
|
2020
Q1 | – | Sell |
-5,694
| Closed | -$494K | – | 1369 |
|
|
2019
Q4 | $494K | Sell |
5,694
-4,669
| -45% | -$383K | 0.06% | 657 |
|
|
2019
Q3 | $832K | Sell |
10,363
-571
| -5% | -$45.8K | 0.11% | 243 |
|
|
2019
Q2 | $875K | Sell |
10,934
-11,544
| -51% | -$884K | 0.1% | 300 |
|
|
2019
Q1 | $1.78M | Buy |
22,478
+8,120
| +57% | +$607K | 0.18% | 86 |
|
|
2018
Q4 | $1.05M | Sell |
14,358
-33,043
| -70% | -$2.33M | 0.12% | 200 |
|
|
2018
Q3 | $3.21M | Buy |
47,401
+37,683
| +388% | +$2.4M | 0.18% | 77 |
|
|
2018
Q2 | $563K | Sell |
9,718
-12,111
| -55% | -$683K | 0.03% | 1094 |
|
|
2018
Q1 | $1.14M | Buy |
21,829
+5,894
| +37% | +$318K | 0.06% | 577 |
|
|
2017
Q4 | $856K | Buy |
15,935
+6,648
| +72% | +$369K | 0.05% | 671 |
|
|
2017
Q3 | $567K | Sell |
9,287
-6,207
| -40% | -$376K | 0.04% | 891 |
|
|
2017
Q2 | $948K | Buy |
15,494
+3,777
| +32% | +$230K | 0.06% | 590 |
|
|
2017
Q1 | $710K | Sell |
11,717
-11,826
| -50% | -$717K | 0.04% | 869 |
|
|
2016
Q4 | $1.32M | Sell |
23,543
-8,482
| -26% | -$496K | 0.08% | 392 |
|
|
2016
Q3 | $1.91M | Buy |
32,025
+722
| +2% | +$42.2K | 0.1% | 252 |
|
|
2016
Q2 | $1.72M | Sell |
31,303
-3,389
| -10% | -$180K | 0.1% | 309 |
|
|
2016
Q1 | $1.75M | Sell |
34,692
-1,432
| -4% | -$70.1K | 0.11% | 237 |
|
|
2015
Q4 | $1.82M | Sell |
36,124
-82,691
| -70% | -$4.17M | 0.09% | 292 |
|
|
2015
Q3 | $5.6M | Buy |
118,815
+61,072
| +106% | +$3.24M | 0.28% | 33 |
|
|
2015
Q2 | $3.14M | Buy |
57,743
+8,136
| +16% | +$456K | 0.12% | 158 |
|
|
2015
Q1 | $2.72M | Sell |
49,607
-680
| -1% | -$38.5K | 0.11% | 193 |
|
|
2014
Q4 | $2.73M | Sell |
50,287
-59,024
| -54% | -$3.29M | 0.19% | 69 |
|
|
2014
Q3 | $6.18M | Buy |
109,311
+8,097
| +8% | +$455K | 0.33% | 50 |
|
|
2014
Q2 | $5.59M | Buy |
+101,214
| New | +$5.52M | 0.25% | 54 |
|
|
2014
Q1 | – | Sell |
-18,208
| Closed | -$870K | – | 1720 |
|
|
2013
Q4 | $870K | Sell |
18,208
-35,923
| -66% | -$1.64M | 0.07% | 452 |
|
|
2013
Q3 | $2.46M | Buy |
54,131
+48,868
| +929% | +$2.23M | 0.19% | 90 |
|
|
2013
Q2 | $233K | Buy |
+5,263
| New | +$235K | 0.03% | 1011 |
|
Other funds holding MRK
GSA Capital Partners's MRK Position: Q2 2026 in Review
GSA Capital Partners opened a new position in Merck (MRK) in Q2 2026: 2,493 shares worth $320K. The stake represents 0.02% of the portfolio and ranks #1264 among its holdings. This is a return to the name: GSA Capital Partners previously reported a position in MRK as recently as Q3 2025.
GSA Capital Partners first reported a position in MRK in Q2 2013 and has held it in 35 quarters since. The position peaked at $6.18M in Q3 2014. 3,824 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- GSA Capital Partners held 2,493 shares of Merck worth $320K as of Q2 2026.
- Merck was a new GSA Capital Partners position in Q2 2026.
- Merck made up 0.02% of GSA Capital Partners's portfolio in Q2 2026, its #1264 holding.
- GSA Capital Partners first reported a position in Merck in Q2 2013 and has held it in 35 quarters since.
- GSA Capital Partners's Merck position peaked at $6.18M in Q3 2014.
- 3,824 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.